X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3) 3
infigratinib (3) 3
animals (2) 2
cancer (2) 2
cholangiocarcinoma (2) 2
growth-factor receptors (2) 2
humans (2) 2
lung cancer (2) 2
mutations (2) 2
neoplasms - pathology (2) 2
selective inhibitor (2) 2
stomatognathic diseases (2) 2
acquired-resistance (1) 1
advanced basic science (1) 1
articles (1) 1
breast cancer (1) 1
breast-cancer (1) 1
cancer therapies (1) 1
care and treatment (1) 1
cell biology (1) 1
circulating tumor cells (1) 1
clinical sequencing (1) 1
cost-benefit analysis (1) 1
cxcr4 (1) 1
driver (1) 1
drug delivery systems (1) 1
drug design (1) 1
endocrine therapy (1) 1
epithelial-to-mesenchymal transition (1) 1
erdafitinib (1) 1
evaluation (1) 1
factor receptor 4 (1) 1
fgfr (1) 1
fibroblast growth factor receptor 2 fusions (1) 1
fibroblast growth factor receptors (1) 1
fibroblast growth factors (1) 1
fibroblast growth factors - metabolism (1) 1
fibroblast-growth-factor (1) 1
foxp3 (1) 1
gatekeeper mutation (1) 1
gene expression (1) 1
gene fusions (1) 1
gene therapy (1) 1
genetic alterations (1) 1
genetic therapy - methods (1) 1
genetic-basis (1) 1
genomes (1) 1
genomic landscape (1) 1
glioblastoma (1) 1
growth factors (1) 1
health aspects (1) 1
homeostasis (1) 1
homeostasis - drug effects (1) 1
immune-checkpoint blocker (1) 1
immunohistochemistry (1) 1
infigratinib sensitivity (1) 1
intra-tumor heterogeneity (1) 1
intrahepatic (1) 1
kinase (1) 1
kinases (1) 1
lymphatic system (1) 1
malignant pleural mesothelioma (1) 1
medical prognosis (1) 1
medicine, research & experimental (1) 1
mesenchymal stem-cells (1) 1
metastasis (1) 1
mirna (1) 1
molecular pathways (1) 1
molecular targeted therapy (1) 1
monoclonal antibodies (1) 1
mutation (1) 1
myeloproliferative syndrome (1) 1
neoplasms - drug therapy (1) 1
nintedanib (1) 1
oncology (1) 1
osteoarthritis (1) 1
ovarian cancer (1) 1
overall survival (1) 1
peritoneal dissemination (1) 1
pharmacology & pharmacy (1) 1
phase-i (1) 1
physiological aspects (1) 1
placebo (1) 1
poster abstracts (1) 1
precision medicine - economics (1) 1
precision medicine - methods (1) 1
properties (1) 1
protein kinase inhibitors - pharmacology (1) 1
receptor protein-tyrosine kinases - antagonists & inhibitors (1) 1
receptor protein-tyrosine kinases - genetics (1) 1
receptor protein-tyrosine kinases - metabolism (1) 1
receptors, fibroblast growth factor - metabolism (1) 1
resistance (1) 1
rodents (1) 1
signal transduction - drug effects (1) 1
stomach cancer (1) 1
targeting angiogenesis (1) 1
therapeutic target (1) 1
tumor microenvironment (1) 1
tumor microenvironment - drug effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CELLS, ISSN 2073-4409, 09/2019, Volume 8, Issue 9, p. 1091
Malignant pleural mesothelioma (MPM) is a devastating malignancy with limited therapeutic options. Fibroblast growth factor receptors (FGFR) and their ligands... 
NINTEDANIB | malignant pleural mesothelioma | PLACEBO | DRIVER | infigratinib sensitivity | FIBROBLAST-GROWTH-FACTOR | FGFR | CELL BIOLOGY | GENE FUSIONS | overall survival | FACTOR RECEPTOR 4 | immunohistochemistry | MUTATIONS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.